Focus:
The main psychoactive component in magic mushrooms, psilocybin, has passed its first clinical safety trial. The drug is now closer to becoming a licensed treatment for depression. Should this happen,...
Many people take for granted that the medication they have been prescribed by their physician will adequately treat or cure their ailment. Yet the reality is that a large number...
As large pharma, biotech, and medical device organizations feel the economic pinch of escalating cost, stricter regulations, and fiercer competition, many seek new ways to cut the costs of development...
The medical device and diagnostic (MDD) industry is experiencing a transformational era due to huge advances in technologies such as AI, robotics, mobile apps, combination products and patient-enabled diagnostic tests.
We live in an era where there is an expectation of immediate results. We connect with other people and with companies via the web, mobile apps, internet chats – all...
As clinical trials get more complex and pressures to deliver increase, trial sponsors are seeking more efficient ways to execute studies.
It’s a well-cited fact that the greatest challenge facing clinical trials today is patient recruitment and retention.
